Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Seferian, A.
1643  Ergebnisse:
Personensuche X
?
1

P24 Safety and tolerability of Eteplirsen in patients 6–48 ..:

Mercuri, E. ; Seferian, A. ; Deconinck, N....
Neuromuscular Disorders.  33 (2023)  - p. S103 , 2023
Link: https://doi.org/10.1016/..
 
?
2

P149 Delayed pulmonary progression in Golodirsen-treated pa..:

Iff, J. ; Tuttle, E. ; Liu, Y....
Neuromuscular Disorders.  33 (2023)  - p. S85 , 2023
Link: https://doi.org/10.1016/..
 
?
3

P147 Six-year long-term safety and efficacy of Golodirsen i..:

Muntoni, F. ; Seferian, A. ; Straub, V....
Neuromuscular Disorders.  33 (2023)  - p. S84 , 2023
Link: https://doi.org/10.1016/..
 
?
4

FP.12 Application for primary endpoint qualification of the..:

Annoussamy, M. ; Eggenspieler, D. ; Seferian, A....
Neuromuscular Disorders.  32 (2022)  - p. S65 , 2022
Link: https://doi.org/10.1016/..
 
?
5

VP.24 T Cell-mediated immune response to dystrophin in Duch..:

Anthony, K. ; Ala, P. ; Catapano, F....
Neuromuscular Disorders.  32 (2022)  - p. S71 , 2022
Link: https://doi.org/10.1016/..
 
?
6

O.06 Long term outcomes for X-Linked myotubular Myopathy (X..:

Shieh, P. ; Kuntz, N. ; Dowling, J....
Neuromuscular Disorders.  32 (2022)  - p. S44 , 2022
Link: https://doi.org/10.1016/..
 
?
7

CLINICAL RESEARCH:

Lilien, C. ; Reyngoudt, H. ; Seferian, A....
Neuromuscular Disorders.  31 (2021)  - p. S49 , 2021
Link: https://doi.org/10.1016/..
 
?
8

CLINICAL TRIAL HIGHLIGHTS:

Shieh, P. ; Kuntz, N. ; Dowling, J....
Neuromuscular Disorders.  31 (2021)  - p. S47 , 2021
Link: https://doi.org/10.1016/..
 
?
9

CONGENITAL MYOPATHIES – CENTRONUCLEAR MYOPATHIES:

Monseur, A. ; Carlin, B. ; Boulanger, B....
Neuromuscular Disorders.  31 (2021)  - p. S57 , 2021
Link: https://doi.org/10.1016/..
 
?
10

SMA: REGISTRIES, BIOMARKERS & OUTCOME MEASURES:

Lilien, C. ; Annoussamy, M. ; Polleur, M....
Neuromuscular Disorders.  30 (2020)  - p. S100 , 2020
Link: https://doi.org/10.1016/..
 
?
11

SMA – THERAPY:

Goff, L. Le ; Seferian, A. ; Phelep, A....
Neuromuscular Disorders.  30 (2020)  - p. S127-S128 , 2020
Link: https://doi.org/10.1016/..
 
?
12

DMD – BIOMARKERS & OUTCOME MEASURES:

Hogrel, J. ; Decostre, V. ; Ledoux, I....
Neuromuscular Disorders.  30 (2020)  - p. S84 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Approche "one-stop-shop" dynamique multiparamétrique pour l..:

Besson, F. ; Fernandez, B. ; Faure, S....
Médecine Nucléaire.  44 (2020)  2 - p. 106 , 2020
Link: https://doi.org/10.1016/..
 
?
14

Relaxométrie T1/T2 pour imagerie TEP-IRM appliquée à l'onco..:

Besson, F. ; Fernandez, B. ; Faure, S....
Médecine Nucléaire.  44 (2020)  2 - p. 134 , 2020
Link: https://doi.org/10.1016/..
 
?
15

Inversion de codage de phase pour corriger les distorsions ..:

Besson, F. ; Fernandez, B. ; Faure, S....
Médecine Nucléaire.  44 (2020)  2 - p. 133 , 2020
Link: https://doi.org/10.1016/..
 
1-15